Ensysce Biosciences Stock Market Value
| ENSCW Stock | USD 0 0 34.29% |
| Symbol | Ensysce |
Ensysce Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ensysce Biosciences' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ensysce Biosciences.
| 12/03/2025 |
| 01/02/2026 |
If you would invest 0.00 in Ensysce Biosciences on December 3, 2025 and sell it all today you would earn a total of 0.00 from holding Ensysce Biosciences or generate 0.0% return on investment in Ensysce Biosciences over 30 days. Ensysce Biosciences is related to or competes with Orgenesis, Mosaic Immunoengineerin, and Biovaxys Technology. Ensysce Biosciences, Inc., a clinical-stage biotech company, engages in developing various prescription drugs More
Ensysce Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ensysce Biosciences' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ensysce Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 121.93 | |||
| Value At Risk | (33.33) | |||
| Potential Upside | 24.0 |
Ensysce Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ensysce Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ensysce Biosciences' standard deviation. In reality, there are many statistical measures that can use Ensysce Biosciences historical prices to predict the future Ensysce Biosciences' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.60) | |||
| Total Risk Alpha | (1.79) | |||
| Treynor Ratio | (0.27) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ensysce Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ensysce Biosciences Backtested Returns
Ensysce Biosciences secures Sharpe Ratio (or Efficiency) of -0.092, which denotes the company had a -0.092 % return per unit of risk over the last 3 months. Ensysce Biosciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Ensysce Biosciences' Mean Deviation of 12.14, variance of 343.75, and Standard Deviation of 18.54 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.87, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ensysce Biosciences will likely underperform. At this point, Ensysce Biosciences has a negative expected return of -2.33%. Please make sure to confirm Ensysce Biosciences' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Ensysce Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.39 |
Poor reverse predictability
Ensysce Biosciences has poor reverse predictability. Overlapping area represents the amount of predictability between Ensysce Biosciences time series from 3rd of December 2025 to 18th of December 2025 and 18th of December 2025 to 2nd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ensysce Biosciences price movement. The serial correlation of -0.39 indicates that just about 39.0% of current Ensysce Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.39 | |
| Spearman Rank Test | -0.7 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Ensysce Biosciences lagged returns against current returns
Autocorrelation, which is Ensysce Biosciences pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Ensysce Biosciences' pink sheet expected returns. We can calculate the autocorrelation of Ensysce Biosciences returns to help us make a trade decision. For example, suppose you find that Ensysce Biosciences has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Ensysce Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Ensysce Biosciences pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Ensysce Biosciences pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Ensysce Biosciences pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Ensysce Biosciences Lagged Returns
When evaluating Ensysce Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Ensysce Biosciences pink sheet have on its future price. Ensysce Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Ensysce Biosciences autocorrelation shows the relationship between Ensysce Biosciences pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Ensysce Biosciences.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Additional Tools for Ensysce Pink Sheet Analysis
When running Ensysce Biosciences' price analysis, check to measure Ensysce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ensysce Biosciences is operating at the current time. Most of Ensysce Biosciences' value examination focuses on studying past and present price action to predict the probability of Ensysce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ensysce Biosciences' price. Additionally, you may evaluate how the addition of Ensysce Biosciences to your portfolios can decrease your overall portfolio volatility.